GlassScriptPhysician profile
Brant M Balthazor
NPI 1548640774
$4,612.91
in general payments reported to CMS, 2019-2025
22 companies · $2,518 in 2025
The $2,518 reported for 2025 was more than what 95% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $38.60 · 2022: $144 · 2023: $369 · 2024: $1,544 · 2025: $2,518.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,101 · Travel and Lodging: $330.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,101.05 |
| Travel and Lodging | $329.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,077.67 | 2024-2025 | Proclaim, Eterna |
| Collegium Pharmaceutical, INC. | $499.87 | 2023-2025 | Belbuca, Nucynta |
| Medtronic, INC. | $332.48 | 2023-2025 | Intellis Adaptivestim, Synchromedii, Vanta Adaptivestim |
| Pfizer INC. | $317.84 | 2023-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $286.07 | 2023-2025 | Relistor |
| Boston Scientific Corporation | $282.14 | 2024-2025 | Intracept, Wavewriter Alpha Prime 16, Infinion 16 |
| Spr Therapeutics, INC | $281.91 | 2023-2025 | Sprint Pns System |
| Abbvie INC. | $276.94 | 2023-2025 | |
| Spinal Simplicity, LLC | $269.89 | 2024-2025 | Ha Minuteman G3-R |
| Ibsa Pharma INC. | $214.26 | 2024-2025 | Tirosint, Licart, Flector |
| Axsome Therapeutics, INC. | $121.36 | 2025 | Symbravo |
| Vertex Pharmaceuticals Incorporated | $120.15 | 2024-2025 | |
| Saluda Medical Americas, INC. | $110.52 | 2024-2025 | Evoke |
| Allergan, INC. | $97.66 | 2022 | |
| Stryker Corporation | $84.58 | 2021-2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $53.08 | 2025 | Senza |
| Tonix Medicines, INC. | $43.20 | 2025 | Tonmya |
| Teva Pharmaceuticals USA, INC. | $36.48 | 2024-2025 | Ajovy |
| Nevro Corp. | $30.52 | 2024 | Senza |
| Tersera Therapeutics LLC | $29.71 | 2025 | Prialt |
| Takeda Pharmaceuticals U.S.A., INC. | $27.79 | 2025 | Cuvitru |
| Pacira Pharmaceuticals Incorporated | $18.79 | 2025 | Iovera, Zilretta, Exparel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brant Balthazor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.